EUVIMEDEUVIMED entdecken
Leserbrief

Nemolizumab‐induced exacerbation of atopic dermatitis

Hirofumi Kamada iD, Nobuyuki Arakawa, Marino Kato, Takayuki Tanji, Daisuke Watabe iD, Naoki Yanagawa, Hiroo Amano

The Journal of Dermatology · 2025-04 · 52 (4)

DOI: 10.1111/1346-8138.17589 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 19.12.2024. Verfasst von Hirofumi Kamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, Iwate Medical University School of Medicine, Morioka, Japan.
  • Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Morioka, Japan.

ORCID-Profile: Hirofumi Kamada, Daisuke Watabe

Zitieren

APA

Kamada, H., Arakawa, N., Kato, M., Tanji, T., Watabe, D., Yanagawa, N., & Amano, H. (2025). Nemolizumab‐induced exacerbation of atopic dermatitis. The Journal of Dermatology, 52(4). https://doi.org/10.1111/1346-8138.17589

Vancouver

Kamada H, Arakawa N, Kato M, Tanji T, Watabe D, Yanagawa N, et al. Nemolizumab‐induced exacerbation of atopic dermatitis. The Journal of Dermatology. 2025;52(4). doi:10.1111/1346-8138.17589

BibTeX
@article{Kamada2025,
  author = {Kamada, Hirofumi and Arakawa, Nobuyuki and Kato, Marino and Tanji, Takayuki and Watabe, Daisuke and Yanagawa, Naoki and Amano, Hiroo},
  title = {Nemolizumab‐induced exacerbation of atopic dermatitis},
  journal = {The Journal of Dermatology},
  year = {2025},
  volume = {52},
  number = {4},
  doi = {10.1111/1346-8138.17589}
}
Kostenlos starten →